In one study, chronic PDE9A inhibitor therapy not only attenuated cardiac hypertrophy, but also significantly reduced interstitial fibrosis and collagen gene expression in pressure-overloaded hearts [8]. Here, PDE9A is linked to cardiac hypertrophy.